Results 1 to 10 of about 48,129 (210)
罕见病研究, 2022 Hemophilia is a group of hereditary hemorrhagic diseases. Hemorrhages mostly occur in musculoskeletal system and is the main cause for disability. Rehabilitation plays an important role in the comprehensive management in hemophilia.
Hemophilia Treatment Center Collaborative Network of China +1 more
doaj +2 more sources
Chinese Expert Consensus on Pharmacokinetics Guided Treatment for Hemophilia A
罕见病研究, 2022 Hemophilia A is an X-chromosome-linked recessive genetic disease that lacks coagulation factor Ⅷ (Factor Ⅷ, FⅧ) and is clinically manifested as spontaneous or excessive bleeding after injury.The current main treatment for hemophilia A is alternative ...
Hemophilia Treatment Center Collaborative Network of China
doaj +2 more sources
Establishment and Evolution of China National Hemophilia Registry
罕见病研究, 2022 Hemophilia is an inherited bleeding disorder and a type of rare disease that is hereditary, lifelong and disabling. The establishment of a National Hemophilia Registry is foundational to treating hemophilia.
XUE Feng, YANG Renchi
doaj +2 more sources
罕见病研究Hemophilia is a collection of hereditary bleeding disorders that are X-linked recessive. Patients often experience recurrent bleeding in joints, leading to a cascade of complications including chronic synovitis, hemophilic arthropathy, muscle atrophy ...
Hemophilia Treatment Center Collaborative Network of China
doaj +2 more sources
GENETIC DIAGNOSTICS OF HEMOPHILIA A [PDF]
Zdravniški Vestnik, 2004 Background. Hemophilia A is a chromosome X-linked bleeding disorder due to mutations in the FVIII gene. There are 163 hemophilia A patients in Slovene registry for Hemophilia.
Maruša Debeljak +2 more
doaj +1 more source
Thrombotic diseases and conditions – diagnosis and monitoring of anticoagulant therapy
Медицинский совет, 2021 Laboratory methods are a very important part of the examination of patients with thrombotic diseases, often putting the final touches on the diagnosis, and in some cases even defining this diagnosis.
A. L. Melkumyan +3 more
doaj +1 more source
Women with Hemophilia: Case Series of Reproductive Choices and Review of Literature
TH Open, 2021 Aim Very little is known regarding reproductive choices, pregnancy, and delivery of women with moderate to severe hemophilia. Our aim was to describe our experience with three hemophiliac women and their journey to achieve motherhood.
Shadan Lalezari +6 more
doaj +1 more source
Personalised Prophylaxis in a Child with Haemophilia A and Type 1 Diabetes
Clinics and Practice, 2021 Poor management of either type 1 diabetes or haemophilia A can lead to complications such as organ dysfunction and haemarthropathy. Here, we describe the case of an 8-year-old boy diagnosed with severe haemophilia A shortly after birth.
Maria Sol Cruz +4 more
doaj +1 more source
Report on diagnosis and treatment of hemophilia in China 2023 [PDF]
Zhenduanxue lilun yu shijian, 2023 In recent years, China attaches great importance to the prevention and treatment of rare diseases. As one of the representative diseases of rare diseases, management of Hemophilia has made great progress in China.
XUE Feng, DAI Jing, CHEN Lixia, LIU Wei, ZHANG Houqiang, WU Runhui, SUN Jing, ZHANG Xinsheng, WU Jingsheng, ZHAO Yongqiang, WANG Xuefeng, YANG Renchi
doaj +1 more source
Research and Practice in Thrombosis and Haemostasis, 2021 Background Emicizumab, a bispecific antibody factor VIII mimetic, is approved for prophylaxis in hemophilia, and has different risks and side effects compared to factor VIII products.
Beth Boulden Warren +9 more
doaj +1 more source